TD Asset Management
YARW

TD Asset Management’s Yarrow Bioscience, Inc. Common Stock YARW Stock Holding History

TD Asset Management’s Portfolio YARW Stock Details YARW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-9
Closed -$143K – 1447
2019
Q4 		$143K Buy
9
+1
+13% +$16.7K ﹤0.01% 1376
2019
Q3 		$132K Hold
8
– – ﹤0.01% 1317
2019
Q2 		$177K Hold
8
– – ﹤0.01% 1304
2019
Q1 		$226K Hold
8
– – ﹤0.01% 1300
2018
Q4 		$116K Hold
8
– – ﹤0.01% 1375
2018
Q3 		$278K Buy
+8
New +$247K ﹤0.01% 1375

Other funds holding YARW

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DA
DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TD Asset Management's YARW Position: Q1 2020 in Review

TD Asset Management sold out of Yarrow Bioscience, Inc. Common Stock (YARW) in Q1 2020, closing a stake of 9 shares — an estimated $143K sold.

TD Asset Management first reported a position in YARW in Q3 2018 and held it in 6 quarters. The position peaked at $278K in Q3 2018. 86 funds tracked by Wall St. Rank hold YARW as of Q1 2020.

  • TD Asset Management reported no remaining Yarrow Bioscience, Inc. Common Stock position as of Q1 2020 after selling out during the quarter.
  • TD Asset Management sold 9 Yarrow Bioscience, Inc. Common Stock shares in Q1 2020, an estimated $143K.
  • TD Asset Management first reported a position in Yarrow Bioscience, Inc. Common Stock in Q3 2018 and held it in 6 quarters.
  • TD Asset Management's Yarrow Bioscience, Inc. Common Stock position peaked at $278K in Q3 2018.
  • 86 funds tracked by Wall St. Rank held Yarrow Bioscience, Inc. Common Stock as of Q1 2020.

Based on TD Asset Management's 13F filing for Q1 2020, filed 15 May 2020.